Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × avelumab × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Glioblastoma 4 Glioma 2 Central Nervous System Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Meningioma 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Lymphoma 1 Brain Neoplasms 1

Interventions

pembrolizumab 2 lenvatinib 1 avelumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02968940 2022-06-29

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

NYU Langone Health

Phase 2 Completed

6 enrolled 10 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡